MONDAY, July 21, 2025 -- For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment...
Vous n'êtes pas connecté
- ONCOLOGYNEWS.COM.AU - A La Une - 15/Jul 23:03
Perioperative chemoimmunotherapy linked to improved outcomes in resectable NSCLC
A large real-world analysis has found that perioperative chemoimmunotherapy is associated with favourable clinical outcomes in patients with resectable stage II to IIIA non–small cell lung cancer (NSCLC). However, the study also reveals that uptake of these therapies remains low, underscoring the need to address barriers to broader adoption. Published in JAMA Network Open, the [...]
Articles similaires
GLP-1 Receptor Agonists May Improve Outcomes in Idiopathic Intracranial Hypertension
drugs.com - 21/Jul 14:07
MONDAY, July 21, 2025 -- For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment...
Patients With Diabetes More Likely to Experience Adverse Financial Outcomes
drugs.com - 28/Jul 21:10
MONDAY, July 28, 2025 -- Patients with type 2 diabetes may experience substantially more adverse financial outcomes compared with patients without...
Why access to stem cell transplants is out of reach for many thalassemia patients in India
wn.com - 25/Jul 11:09
India carries the world’s most significant burden of thalassemia, with an estimated 150,000 patients and 12,000 new cases every year. While medical...
Why access to stem cell transplants is out of reach for many thalassemia patients in India
wn.com - 25/Jul 11:09
India carries the world’s most significant burden of thalassemia, with an estimated 150,000 patients and 12,000 new cases every year. While medical...
Modified personalised cancer vaccine generates powerful immune response
oncologynews.com.au - 17/Jul 16:06
Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of...
Vermont engineer revives pay phones for free calls in areas with poor cell service
courthousenews.com - 22/Jul 19:50
He plans to continue covering the costs associated with each phone, but noted that may change as the project scales.
Many Ineligible for Clinical Trial Could Benefit From Teclistamab for Multiple Myeloma
drugs.com - 16/Jul 15:07
WEDNESDAY, July 16, 2025 -- In a study published online July 9 in Blood Cancer Discovery, real-world outcomes are described for teclistamab, a...
Many Ineligible for Clinical Trial Could Benefit From Teclistamab for Multiple Myeloma
drugs.com - 16/Jul 15:07
WEDNESDAY, July 16, 2025 -- In a study published online July 9 in Blood Cancer Discovery, real-world outcomes are described for teclistamab, a...
COVID-19 Vaccine Boosters Aid Outcomes in Patients With Cancer
drugs.com - 21:03
TUESDAY, July 29, 2025 -- COVID-19 vaccination boosters protect people with cancer developing from severe COVID-19, according to a study published...
Les derniers communiqués
-
Evergreen Elevate Heads to Australia to Empower MSPs with Valuable Strategies and Insights on Better M&A Practices
Evergreen Elevate - 29/07/2025